A Step Forward for Long-Acting PCSK9 Inhibition: Improvements Without a Breakthrough

J Am Coll Cardiol. 2024 Nov 12;84(20):2048-2050. doi: 10.1016/j.jacc.2024.09.019. Epub 2024 Oct 9.

¹ Academic Research Organization, Hospital Israelita Albert Einstein and Heart Institute (InCor) University of Sao Paulo, Sao Paulo, Brazil.
² Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.
³ Center for Prevention of Cardiovascular Disease, Section on Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Electronic address: mdshapir@wakehealth.edu.

No abstract available

Keywords: LDL-C; PCSK9; lipoproteins; mixed hyperlipemia; nonfamilial hypercholesterolemia; recaticimab.

Publication types